Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 9/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | VCP | P55072 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | PNP | P00491 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | EDNRA | P25101 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7620005 | 0.90 | HPRT1 (0.49) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL6840618 | 0.88 | PDE3A (0.59) | HPRT1MEN1KMT2ABLMPDE3A | |
| Hydrochloric Acid SCHEMBL5165704 | 0.87 | HBB (0.58) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL5166552 | 0.86 | MEN1 (0.54) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL7622544 | 0.85 | HPRT1 (0.51) | HPRT1MEN1KMT2ABLMPDE3A | |
| Hydrochloric Acid SCHEMBL6380562 | 0.81 | HPRT1 (0.51) | HPRT1MEN1KMT2ABLMALDH1A1 | |
| Valine SCHEMBL8868227 | 0.79 | PDE3A (0.51) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL8712058 | 0.79 | MEN1 (0.49) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL21162677 | 0.76 | PDE3A (0.55) | HPRT1MEN1KMT2ABLMPDE3A | |
| SCHEMBL7749536 | 0.76 | HPRT1 (0.67) | HPRT1MEN1KMT2ABLMPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324381-B2 | Preparation of ester of purine derivatives | CIPLA LIMITED (IN) | 2012-12-04 | — | — | US | disclosed |
| US-20070225305-A1 | Preparation of ester of purine derivatives | CIPLA LIMITED (IN) | 2007-09-27 | — | — | US | disclosed |
| EP-1837336-A1 | Preparation of valganciclovir | Cipla Ltd. (IN) | 2007-09-26 | — | — | EP | disclosed |
| EP-0885224-B1 | PROCESS FOR PREPARING GANCICLOVIR DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2002-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225305-A1 | Preparation of ester of purine derivatives | PNP, TYMP, MTAP | HPRT1 17/4885MEN1 3875/4885KMT2A 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.